)
Bio Green Med Solution (BGMS) investor relations material
Bio Green Med Solution Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Completed acquisition of Fitters Sdn. Bhd. in September 2025, shifting focus to fire safety protection and distribution.
Liquidated UK subsidiary and sold Plogosertib drug asset, strengthening the balance sheet.
Declared and paid a quarterly cash dividend on preferred stock in early 2026.
Financial highlights
Cash and cash equivalents were $3.5 million as of December 31, 2025, down from $3.8 million a year earlier.
Net cash used in operating activities was $4.8 million for 2025, improved from $8.0 million in 2024.
Net loss for 2025 was $3.0 million, significantly reduced from $11.2 million in 2024.
Product revenue from fire safety equipment was $0.7 million for both Q4 and full year 2025.
Total other income, net, was $5.4 million for 2025, mainly from a $4.9 million gain on deconsolidation of the former subsidiary.
Outlook and guidance
Current cash resources are expected to fund planned expenditures into Q3 2026.
- Lower Q2 loss and R&D spend, but cash runway and compliance risks persist.BGMS
Q2 20241 Feb 2026 - FADRA demonstrates durable responses in biomarker-driven cancer trials; PLOGO reformulation underway.BGMS
H.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026 - Stockholders will vote on key proposals that could shift control and restructure the company's capital.BGMS
Proxy Filing2 Dec 2025 - Shareholders to vote on equity issuances, reverse split, and governance changes to secure funding.BGMS
Proxy Filing2 Dec 2025 - Shareholders to vote on equity issuances, reverse split, and governance changes to ensure compliance.BGMS
Proxy Filing2 Dec 2025 - Virtual annual meeting to vote on directors, equity plan amendment, and executive pay.BGMS
Proxy Filing2 Dec 2025 - Virtual meeting to vote on director elections, equity plan amendment, and executive pay.BGMS
Proxy Filing2 Dec 2025 - Key votes include share issuance, corporate name change, and governance amendments.BGMS
Proxy Filing2 Dec 2025 - Biopharma pivots to single cancer drug, acquires Fitters, faces urgent funding and integration risks.BGMS
Registration Filing29 Nov 2025
Next Bio Green Med Solution earnings date
Next Bio Green Med Solution earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)